bioRxiv / medRxiv
open access
Pleiotropic genetic architecture linking schizophrenia and substance use disorders
Schizophrenia (SCZ) frequently co-occurs with substance use disorders (SUDs), yet the genetic basis of this comorbidity remains unclear. Using the latest European-ancestry genome-wide association studies (GWAS) for SCZ, cannabis use disorder (CanUD), opioid use disorder (OUD), problematic alcohol us
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Neurophysiological Studies in Schizophrenia and Psychiatric Disorders#854052
- GWAS of lifetime cannabis use reveals new risk loci, genetic overlap with psychiatric traits, and a causal effect of schizophrenia liability#1132961
- Bipolar and Schizophrenia Consortium for Parsing Intermediate Phenotypes#1173848
- Psychosis and Affective Research Domains and Intermediate Phenotypes#1072698
- Identifying and Characterising Common Genetic Differences in Schizophrenia and Bipolar Disorder#459890
Record · ID 1169745
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive